Thu. 9 May 2024, 8:36am ET
Benzinga
Earnings, Earnings Misses, News
Quoin Pharmaceuticals (NASDAQ:QNRX) reported quarterly losses of $(1.11) per share which missed the analyst consensus estimate of $(0.76) by 46.05 percent. This is a 72.79 percent increase over losses of $(4.08) per share from the same period last year.